Gilead Sciences

Gilead Sciences, Inc. is a prominent American biopharmaceutical company based in Foster City, California. Founded in 1987, Gilead focuses on discovering, developing, and commercializing innovative medicines for life-threatening diseases. The company specializes in three main therapeutic areas: virology, oncology, and inflammation. Its virology efforts address conditions such as HIV/AIDS and viral hepatitis, while oncology focuses on cancer treatments and cell therapy. Inflammation therapies target various conditions in rheumatology, pulmonology, dermatology, and gastroenterology.

With a workforce of approximately 14,000 to 18,000 employees across more than 35 countries, Gilead is committed to advancing therapies for unmet medical needs. The company offers a diverse portfolio of branded medicines, including treatments for HIV/AIDS, viral hepatitis, and oncology, as well as therapies for respiratory and infectious diseases. Gilead markets its products to healthcare providers worldwide, aiming to improve care for patients facing serious health challenges.